I agree. Hardball would be a naive strategy. Theirs isn't the only immunotherapy 'booster' in the marketplace.
Information must be given to the market in the event it occurs. Lack of market information on these matters confirms the inference that nothing has gotten past the chummy-chat-amongst-friends.
VLA Price at posting:
63.0¢ Sentiment: Buy Disclosure: Held